2024 Pharm Exec Top 50 Companies
Jun 14, 2024 · As we noted in last year’s report, Novo Nordisk and Eli Lilly, competing in the lucrative GLP-1 receptor agonist space that, of late, has captivated the US and beyond in weight loss, are knocking loudly on the top-10 door.Both companies, who own the highest market caps, respectively, in pharma, turned in massive growth in our latest Pharma 50.
Pharmaceutical Executive
Master the Science of Success through aspirational coverage for executive-level decisions, leadership, management, strategy and commercialization professionals.
Understanding IDNs and What They Mean to the Pharmaceutical …
Aug 2, 2024 · Integrated Delivery Networks have changed the healthcare landscape over the past decade. Greg Skalicky, president and chief revenue officer at EVERSANA, spoke with Pharmaceutical Executive about the ways that commercialization teams are working with these networks to bring drugs to markets.
Pharmaceutical Executive - PharmExec
Master the Science of Success through aspirational coverage for executive-level decisions, leadership, management, strategy and commercialization professionals.
Four for 2024: Predictions for the Future of Pharmacy Technology
Jan 9, 2024 · What does the future hold for pharmacy technology? It’s a question we’re asking across the industry, but as a pharmacist who works to improve technology to make it easier and safer to help care for patients, I'm sharing four predictions for 2024.
2024 Apex Awards Winners - pharmexec.com
Company: Elevar Therapeutics Agency: The Agency Network at MJH LifeSciences Campaign: Elevar uHCC Disease Awareness Campaign
Amgen's Novel Weight Loss Drug Shows Potential for Longer …
Feb 6, 2024 · Amgen’s novel weight loss drug candidate maridebart cafraglutide (MariTide) showed significant promise in a Phase I trial (NCT04478708), with data suggesting longer lasting and durable reductions in body weight compared with the popular glucagon-like peptide (GLP)-1 agonists currently on the market—Novo Nordisk’s Wegovy (semaglutide) and Eli …
Biopharma Trends in 2024 and Beyond - PharmExec
Jan 17, 2024 · The Inflation Reduction Act (IRA), mergers and acquisitions, obesity-control drugs, and artificial intelligence (AI) dominated the pharma industry’s headlines in 2023.
Advantages & Disadvantages of Using Compounded Medications
Oct 24, 2024 · Scott Brunner, CEO, and Tenille Davis, Chief Advocacy Officer, of the Alliance for Pharmacy Compounding discuss how compounded medications differ from commercially available drugs in terms of their manufacturing process, quality standards, and more.
Out-licensing Deals Between Chinese Pharma and Global
Jan 19, 2024 · In 2023, we witnessed considerable changes in the Chinese pharmaceutical market, especially a booming market of innovative drugs and out-licensing arrangements between China-based biopharma companies and international firms.